To evaluate the potential of urine sCD163 as a biomarker in LN, and to investigate its correlation with clinical indices and pathological attributes, we assayed urine sCD163 in SLE patients with diverse disease activities from multiple ethnicities. Here, CD163 is linked to lobular neoplasia.